Search results
FDA Staff Proposes Narrow Approval for Lilly’s Alzheimer’s Drug
Bloomberg· 3 days agoUS drug regulatory staffers are considering a more targeted approval for Eli Lilly & Co.’s...
Eli Lilly’s Alzheimer’s drug to face safety, dosing scrutiny from FDA advisers
Market Watch· 2 days agoIn a briefing document prepared for the advisory committee, the FDA raised questions about a unique...
FDA lays out donanemab concerns ahead of meeting, as Lilly vigorously defends safety
FierceBiotech· 3 days agoThe docs for Eli Lilly’s donanemab advisory committee meeting are in: the FDA has raised concerns...
After FDA setback, psychedelic drugmakers distance themselves from a pioneer
Washington Post via Yahoo News· 2 hours agoDoblin has said MDMA could help reduce the world’s trauma, not eliminate it. Originally moved June...
FDA Reviewers Question Patient Selection for Alzheimer's Drug Candidate
MedPage Today· 4 days agoIf approved, donanemab will be the third amyloid-targeted drug to come to market: the first being...
US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59
Reuters via Yahoo News· 2 days ago(Reuters) -The U.S. Food and Drug Administration approved the expanded use of GSK's respiratory...
FDA clears GSK's RSV vaccine for adults ages 50-59
United Press International via Yahoo News· 1 day agoThe U.S. Food and Drug Administration on Friday approved GSK's respiratory syncytial virus vaccine for high-risk adults ages 50 to 59, expanding the...
FDA Reverses Juul Ban. What Comes Next?
InvestorPlace· 2 days agoThe FDA lifted its ban on Juul’s products after conducting additional studies of the products. Also flavoring the FDA’s</ ...
Abortion, guns and more: These are the Supreme Court's remaining cases
WTAE Pittsburgh· 22 minutes agoThe Supreme Court is turning toward the final, frenzied weeks of its term, readying potential blockbuster decisions on abortion, guns and former President Donald Trump's claims ...
FDA Panel Votes Against MDMA As PTSD Treatment—A Potential Hitch For Drug’s Approval
Forbes· 6 days agoThe FDA will make a final decision on the proposal on Aug. 11 and does not have to follow the panel’...